Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

McKesson
Moodys
Mallinckrodt
Boehringer Ingelheim
Dow
Baxter

Last Updated: May 21, 2022

Qilu Company Profile


✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for QILU, and what generic and branded alternatives to QILU drugs are available?

QILU has twenty-one approved drugs.



Summary for Qilu
US Patents:0
Tradenames:18
Ingredients:18
NDAs:21

Drugs and US Patents for Qilu

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Qilu TENOFOVIR DISOPROXIL FUMARATE tenofovir disoproxil fumarate TABLET;ORAL 209498-002 Mar 2, 2018 AB RX No No See Plans and Pricing See Plans and Pricing
Qilu SOLIFENACIN SUCCINATE solifenacin succinate TABLET;ORAL 209333-001 May 20, 2019 AB RX No No See Plans and Pricing See Plans and Pricing
Qilu CEFAZOLIN SODIUM cefazolin sodium INJECTABLE;INJECTION 209217-001 Oct 17, 2018 AP RX No Yes See Plans and Pricing See Plans and Pricing
Qilu Pharm Hainan OXALIPLATIN oxaliplatin INJECTABLE;INTRAVENOUS 204368-003 Jun 7, 2016 RX No Yes See Plans and Pricing See Plans and Pricing
Qilu CEFTRIAXONE ceftriaxone sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 203702-002 Jun 29, 2016 AP RX No No See Plans and Pricing See Plans and Pricing
Qilu OLANZAPINE olanzapine TABLET;ORAL 204319-003 Jan 27, 2016 AB RX No No See Plans and Pricing See Plans and Pricing
Qilu Pharm Hainan DECITABINE decitabine INJECTABLE;INTRAVENOUS 212826-001 Apr 12, 2021 AP RX No No See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
Mallinckrodt
Dow
Harvard Business School
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.